Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Agency: National Institutes of Health
NAICS: 621511 - Medical Laboratories
Posted: 2023-08-24
Deadline: 2027-01-07

Matchawards

To use the MatchAwards web application, please enable JavaScript. Alternatively, try one of the native apps for MatchAwards for your platform.